WeVote

Bill

Bill

H 1227

An Act relative to patient access to biomarker testing to provide appropriate therapy

194th Legislature (2025-2026) Introduced by Jim Arciero and 60 co-sponsors

Massachusetts bill requiring insurers to cover biomarker cancer testing without prior authorization to expedite patient access to targeted therapy treatment decisions.

Hearing rescheduled to 04/29/2025 from 10:00 AM-01:00 PM in A-2 and Virtual Hearing updated to New End Time
0

WeVote — Public opinion

No community votes yet. Be the first to weigh in from the Vote tab.

Bill text & amendments

No documents yet

The official bill text and any amendments will be posted here once available.